Press release
United States RNA-based Therapies Market Forecast 2025-2033: mRNA, siRNA & Gene-Modulating Drugs, Growth Drivers, Key Players & Investment Opportunities
RNA-based Therapies Market
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/rna-based-therapies-market?kb
United States - Recent Industry Developments
✅ November 2025: Moderna advanced Phase III clinical trials for RNA-based therapeutics targeting rare genetic disorders beyond mRNA vaccines.
✅ October 2025: Alnylam strengthened commercial rollout of RNAi therapies for cardiovascular risk reduction across U.S. healthcare networks.
✅ September 2025: The FDA issued accelerated approval pathway updates to support rapid development of next-generation RNA-based immunotherapies.
GCC - Recent Industry Developments
✅ November 2025: UAE healthcare authorities announced investment programs to establish regional RNA therapy R&D and clinical trial facilities.
✅ October 2025: Saudi Arabia partnered with biotech leaders to develop localized RNA-based therapeutic manufacturing capabilities.
✅ September 2025: Qatar expanded precision medicine programs integrating RNA-based treatment strategies for hereditary disease patients.
MENA Region - Recent Industry Developments
✅ November 2025: Egypt launched collaborative research in RNA-driven oncology therapeutics with global pharma organizations.
✅ October 2025: Morocco prioritized RNA-based antiviral formulations in national innovation strategies for infectious disease preparedness.
✅ September 2025: Israel introduced next-gen self-amplifying RNA (saRNA) platforms to accelerate clinical translation of cancer vaccines.
Key Players:
Sarepta Therapeutics, Alnylam Pharmaceuticals, NS Pharma, Pfizer, Modern Therapeutics, Novartis, Biogen, and Novo Nordisk
Latest M&A
» Novartis confirmed a $12 billion acquisition of Avidity Biosciences in 2025, enhancing its neuromuscular RNA therapy pipeline with late-stage assets and precision delivery technology.
» Sanofi acquired Blueprint Medicines for $9.5 billion, incorporating RNA and gene therapy assets to expand its precision medicine offerings.
» AbbVie agreed to pay $2.1 billion for Capstan Therapeutics, gaining CAR-T and RNA delivery capabilities targeting autoimmune diseases, showcasing robust RNA-related deal activity.
Growth Forecast Projection:
The Global RNA-based Therapies Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global RNA-based Therapies Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Latest Drugs and Product Launches
1. Astellas expanded FDA-approved indications for IZERVAYTM (avacincaptad pegol) for treating Geographic Atrophy, demonstrating RNA-based drug approvals expanding into retinal diseases.
2. Moderna drove oncology mRNA vaccine programs with long-term clinical data indicating improved patient outcomes, reinforcing RNA's expanding therapeutic reach.
3. BioNTech and other biotech firms advanced personalized mRNA cancer vaccines and immunotherapies in trials showing promising immune responses.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=rna-based-therapies-market?kb
Key Segmentation:
By Type: (Antisense Oligonucleotides (ASO), RNA interference, CRISPR/Cas-based RNA editing system, mRNA vaccines, RNA Aptamers, Others)
By Indication: (Rare Genetic Diseases, Oncology, Infectious Diseases, Neuromuscular, Others)
By End User: (Hospitals & Clinics , Research Institutes , Pharmaceutical & Biotech Companies)
Regional Analysis for Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.
Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.
Chapter 3: Offers an in-depth look at the competitive landscape among RNA-based Therapies producers, including revenue shares, strategic moves, and recent mergers and acquisitions.
Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.
Chapters 5 & 6: Analyze RNA-based Therapies revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.
Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.
Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.
Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.
Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/rna-based-therapies-market?kb
Clinical Trials
✦ Over 2,500 active RNA therapeutic clinical trials globally in 2025, addressing rare and common diseases with siRNA, mRNA, and antisense oligonucleotide modalities.
✦ Key ongoing trials include oral RNA drugs for cardiometabolic diseases and RNAi therapies combined with checkpoint inhibitors for cancer.
✦ Regulatory frameworks are evolving, with focus on safety, delivery efficacy, and functional outcome endpoints to support accelerated approval pathways.
Have any Enquiry of This Report @ https://www.datamintelligence.com/enquiry/rna-based-therapies-market?kb
Latest Investments and Project Hubs
1. Montreal's CQDM launched a global RNA therapy innovation hub with $20.3 million government funding to boost RNA therapeutic research and accelerators in 2024-2025.
2. Haya Therapeutics raised $65 million Series A for RNA therapeutics targeting rare neurological and hepatic diseases, reflecting broad investor interest.
3. Quebec and other innovation hubs are leveraging AI and advanced RNA delivery platforms to overcome historic delivery challenges and expand RNA therapy applications
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Related Reports:
Small Interfering RNA (siRNA) Therapeutics Market:- https://www.datamintelligence.com/download-sample/small-interfering-rna-therapeutics-market?kb
RNAi Therapeutics Market: https://www.datamintelligence.com/research-report/rnai-therapeutics-market?kb
mRNA Vaccines Market: https://www.datamintelligence.com/research-report/mrna-vaccines-market---pipeline-insights?kb
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States RNA-based Therapies Market Forecast 2025-2033: mRNA, siRNA & Gene-Modulating Drugs, Growth Drivers, Key Players & Investment Opportunities here
News-ID: 4296623 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
AI Recruitment Market Outlook 2025-2030: North America Leads with 41% Share | CA …
The Global AI Recruitment Market was valued at approximately USD 596.16 million in 2025 and is projected to reach around USD 860.96 million by 2030, growing at a CAGR of about 7.63 percent during the forecast period. Market expansion is driven by rising adoption of AI-powered hiring tools that automate candidate sourcing, resume screening, skill assessments and onboarding. Organizations are increasingly deploying AI to reduce hiring time, improve candidate matching…
AI in Renewable Energy Market Set for Explosive Growth to USD 4.85 Billion by 20 …
The Global AI in Renewable Energy Market reached approximately USD 0.85 billion in 2024 and is projected to reach USD 4.85 billion by 2032, growing at a CAGR of 24.32% during the forecast period from 2025 to 2032.
This significant growth is driven by the increasing global transition to clean energy, the critical need for grid stability amid the intermittency of renewable sources, and rising demand for enhanced operational efficiencies. Key…
United States Floating Solar Panels Market Growing at 16.43% CAGR 2026-2033; Asi …
Global Floating Solar Panels Market size reached US$ 55.11 million in 2024 and is expected to reach US$ 84.90 million by 2032, growing with a CAGR of 5.55% during the forecast period 2025-2032.
Download your exclusive sample report today: (corporate email gets priority access):https://www.datamintelligence.com/download-sample/floating-solar-panels-market?pratik
The global floating solar panels market is experiencing significant growth, driven by technological advancements and the increasing need for efficient land use in renewable energy generation.
United…
Asthma and COPD Devices Market Outlook 2024-2033: North America Leads with 37% S …
The Global Asthma and COPD Devices Market was valued at approximately USD 47.8 billion in 2024 and is projected to reach around USD 70.5 billion by 2033, growing at a CAGR of about 4.4 percent during the forecast period. Demand continues to rise due to increasing prevalence of asthma and chronic obstructive pulmonary disease, higher pollution levels, expanding aging populations, and greater awareness of respiratory care. Inhalers, including metered-dose inhalers…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
